Insider holders · CIK 0001654151
Deciphera Pharmaceuticals, Inc. · DCPH
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Brightstar Associates LLC10% Owner | 16,572,370 | — | 16,572,370 | Oct 2, 2017 · 4:31 pm EDT | Form 4 |
| New Leaf Biopharma Opportunities I, L.P.10% Owner | — | 2,146,308 | 2,146,308 | Oct 2, 2017 · 4:42 pm EDT | Form 4 |
| New Leaf BPO Associates I, L.P.10% Owner | — | 2,146,308 | 2,146,308 | Oct 2, 2017 · 4:42 pm EDT | Form 4 |
| New Leaf Venture Management III, L.L.C.10% Owner | — | 2,146,308 | 2,146,308 | Oct 2, 2017 · 4:42 pm EDT | Form 4 |
| New Leaf Venture Associates III, L.P.10% Owner | — | 2,146,308 | 2,146,308 | Oct 2, 2017 · 4:42 pm EDT | Form 4 |
| New Leaf Ventures III, L.P.10% Owner | — | 2,146,308 | 2,146,308 | Oct 2, 2017 · 4:42 pm EDT | Form 4 |
| Liam RatcliffeDirector | — | 2,146,308 | 2,146,308 | Oct 2, 2017 · 4:40 pm EDT | Form 4 |
| Daniel Lee FlynnChief Scientific Officer | 24,500 | 55,270 | 79,770 | Feb 25, 2019 · 4:16 pm EST | Form 4 |
| Daniel C. MartinChief Commercial Officer | 20,000 | — | 20,000 | Sep 20, 2018 · 4:17 pm EDT | Form 4 |
| James Arthur BristolDirector | 0 | — | 0 | Feb 19, 2019 · 7:25 pm EST | Form 4 |
| Michael Douglas TaylorPresident and CEO | 0 | — | 0 | Feb 19, 2019 · 7:24 pm EST | Form 4 |
| Thomas Patrick KellyChief Financial Officer | 0 | — | 0 | Feb 20, 2019 · 8:37 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.